Botulinum toxin type A on an intranasal sponge for chronic allergic rhinitis: Randomized clinical trial

Iranian Rehabilitation Journal

Volumn 11, Issue 18, 2013, Pages 5-11

  Shemshadi, Hashem ^a   Azimian, Mojtaba ^a   Akbari Kamrani, Ahmad Ali ^a   Onsori, Mohammad Ali ^b  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antihistamine; Botox; Botulinum Toxin A; Chronic allergic rhinitis; Conventional medications; Corticosteroids; Disease rehabilitations; Dysport; Intranasal injection; Intranasal sponge; Unsuccessful treatments

Indexed keywords

EID: 84979626125     PISSN: 17353602     EISSN: 17353610     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Samolinski B, Sybilski AJ, Raciborski F, Tomaszewska A, Samel-Kowalik P, Walkiewicz A, et al. Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study. Otolaryngol Pol Pol Otolaryngol. 2009;63 (4):324-30
2. Topal O, Erbek SS, Erbek S, Cakmak O. [Epidemiological characteristics, distribution of allergens, and symptom severity in patients with perennial allergic rhinitis, living in Konya region]. KBB J Ear Nose Throat. 2008;18 (4):227-31
3. Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012;6 (1):11-23
4. Bascom R. Environmental factors and respiratory hypersensitivity: the Americas. Toxicol Lett. 1996;86 (2-3):115-30
5. Zhuang Y, Sun XM, Wang XY, Shi HY, Zhang ZG, Wang Q. [The influence of ambient air pollutants on outpatient visits for allergic disease and pollinosis]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010;44 (12):1121-7
6. Alsowaidi S, Abdulle A, Shehab A, Zuberbier T, Bernsen R. Allergic rhinitis: prevalence and possible risk factors in a Gulf Arab population. Allergy. 2010;65 (2):208-12
7. Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis. 2012;6 (1):25-39
8. Rutkowski R, Kosztyla-Hojna B, Rutkowska J. [Allergic rhinitis-an epidemiological, economical and social problem of the XXI century]. Pneumonol Alergol Pol. 2008;76 (5):348-52
9. Zidarn M, Kosnik M, Silar M, Grahek A, Korosec P. Rhinitis symptoms caused by grass pollen are associated with elevated basophile allergen sensitivity and a larger grass-specific immunoglobulin E fraction. Clin Exp Allergy. 2012;42 (1):49-57
10. Wood AJ, Douglas RG. Pathogenesis and treatment of chronic rhinosinusitis. Postgrad Med J. 2010;86 (1016):359-64
11. Zhao Y, Woo KS, Ma KH, van Hansselt CA, Wong KC, Cheng KF, et al. Treatment of perennial allergic rhinitis using Shi-Bi-Lin, a Chinese herbal formula. J Ethnopharmacol. 2009;122 (1):100-5
12. Zhang YQ. Clinical experience in acupuncture treatment of allergic rhinitis. J Tradit Chin Med. 2009;29 (3):186-9
13. Zielinska Blizniewska H, Repetowski M, Milonski J, Olszewski J. [Comparative assessment of cryosurgical treatment results in allergic and non-allergic rhinitis]. Otolaryngol Pol Pol Otolaryngol. 2011;65 (4):276-80
14. Zhu L, Zhu L, Chen R, Tao Q, Lu J, Cheng L. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;46 (12):986-91
15. Zhang L, Xu G, Wang X, Liu S, Li Y, Wang S, et al. [Treatment of allergic rhinitis with nasal mometasone furoate]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;44 (6):455-9
16. Zeldin Y, Weiler Z, Magen E, Tiosano L, Kidon MI. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life. Isr Med Assoc J IMAJ. 2008;10 (12):869-72
17. Zhang CS, Yang AW, Zhang AL, Fu WB, Thien FUK, Lewith G, et al. Ear-acupressure for allergic rhinitis: a systematic review. Clin Otolaryngol. 2010;35 (1):6-12
18. Zagolski O. Factors affecting outcome of inferior turbinate mucotomy in treatment of postnasal drip syndrome. Am J Rhinol Allergy. 2010;24 (6):459-63
19. Yao K, Sato K, Usui D, Kurihara R, Okamoto M, Iguchi Y, et al. Chemosurgery with trichloroacetic acid for allergic rhinitis: evaluation of the efficacy in terms of inhibition of Th2 cell infiltration. Auris Nasus Larynx. 2009;36 (3):292-9
20. Farahvash MR, Arad S. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. J Cosmet Dermatol. 2007;6 (3):152-8
21. Wollina U, Konrad H, Petersen S. Botulinum toxin in dermatology-beyond wrinkles and sweat. J Cosmet Dermatol. 2005;4 (4):223-7
22. Singer C. [Indications and management of botulinum toxin]. Rev Neurol. 1999;29 (2):157-62
23. Klap P. [Botulinium toxin in ENT]. Ann Otolaryngol Chir Cervicofac. 2006;123 (6):306-11
24. Klap P, Cohen M, Van Prooyen Keyzes S, Perrin A, Ayache D. [Laryngeal dystonia]. Rev Neurol. 2003;159 (10 (1)):916-22
25. Gracco A, Tracey S. Botox and the gummy smile. Prog Orthod. 2010;11 (1):76-82
26. Unal M. Botulinum toxin-physiology and applications in head and neck disorders. Head Neck. 2006;28 (9):861
27. Braun T, Gurkov R, Kramer MF, Krause E. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study. Am J Otolaryngol. 2012;33 (1):64-7
28. Nowak K, Szyfter W. [Application of botulinum toxin A in chronic intrinsic rhinitis]. Otolaryngol Pol Pol Otolaryngol. 2011;65 (2):103-5
29. Rapiejko P, Piekosz Orzechowska B, Jurkiewicz D. [Assessment of Polish physicians' therapy behaviour and patterns of prescribing antihistaminic medicines in day-today outpatient care]. Otolaryngol Pol Pol Otolaryngol. 2009;63 (6):509-12
30. Woo JM, Gibbons RD, Qin P, Komarow H, Kim JB, Rogers CA, et al. Suicide and prescription rates of intranasal corticosteroids and nonsedating antihistamines for allergic rhinitis: an ecological study. J Clin Psychiatry. 2011;72 (10):1423-8
31. Rohrbach S, Laskawi R. Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec. 2001;63 (6):382-4